Complete Up To Date Information about Cytobin Tablets.
NADA Number: 014-366 | |
| Proprietary Name |
Cytobin Tablets |
|---|---|
| Sponsor |
Pfizer, Inc. |
| Sponsor Address |
235 East 42d St. New York, NY 10017 USA |
| Ingredients |
Liothyronine Sodium |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
520.1284 Sodium liothyronine tablets. Specifications: Sodium liothyronine tablets consist of tablets intended for oral administration which contain liothyronine at 60 or 120 micrograms per tablet, as the sodium salt. Conditions of use: Dogs Amount: It is administered orally to dogs at levels up to 12.8 micrograms per kilogram of body weight per day. Dosage should be adjusted according to the severity of the condition and the response of the patient. Dosage at the total replacement level (12.8 g per kilogram of body weight) should be considered for initiating therapy and then titrated downward for optimum maintenance effect. Twice daily administration is recommended. Indications: It is indicated in cases of hypothyroidism in dogs. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |